173 related articles for article (PubMed ID: 25638802)
1. Tumor-associated macrophages in diffuse large B-cell lymphoma.
Kridel R; Steidl C; Gascoyne RD
Haematologica; 2015 Feb; 100(2):143-5. PubMed ID: 25638802
[No Abstract] [Full Text] [Related]
2. Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.
Riihijärvi S; Fiskvik I; Taskinen M; Vajavaara H; Tikkala M; Yri O; Karjalainen-Lindsberg ML; Delabie J; Smeland E; Holte H; Leppä S
Haematologica; 2015 Feb; 100(2):238-45. PubMed ID: 25381134
[TBL] [Abstract][Full Text] [Related]
3. Successful chimeric antigen receptor T cell therapy in a case of primary testicular diffuse large-B-cell lymphoma with central nervous system progression.
Ping N; Qu C; Bai L; Kang L; Chen X; Wu Q; Xia F; Yu L; Yao H; Wu D; Jin Z
Leuk Lymphoma; 2019 Nov; 60(11):2814-2816. PubMed ID: 31088197
[No Abstract] [Full Text] [Related]
4. Heart as the site of first relapse in diffuse large B-cell lymphoma.
Singhal M; Raina V; Medhi K; Gupta C; Reddy RM
Indian J Cancer; 2010; 47(2):220-2. PubMed ID: 20448391
[No Abstract] [Full Text] [Related]
5. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
6. Early CNS relapse in a good-risk primary mediastinal large B-cell lymphoma after combined chemo- and radio-therapy.
Sasaki M; Sugimoto K; Masuda A; Tsukune Y; Yahata Y; Komatsu N
J Neurooncol; 2010 Sep; 99(2):295-6. PubMed ID: 20151175
[No Abstract] [Full Text] [Related]
7. Clinical approach to diffuse large B cell lymphoma.
Caimi PF; Hill BT; Hsi ED; Smith MR
Blood Rev; 2016 Nov; 30(6):477-491. PubMed ID: 27596109
[TBL] [Abstract][Full Text] [Related]
8. [Intra-tumoral hemorrhage of a relapsed CNS diffuse large B-cell lymphoma: a case report].
Kim TK; Wajima D; Yonezawa T; Takamura Y; Miyamae S
No Shinkei Geka; 2014 Jul; 42(7):651-8. PubMed ID: 25006106
[TBL] [Abstract][Full Text] [Related]
9. Polymyositis following autologous haematopoietic stem cell transplantation.
Hedermann G; Marquart HV; Vissing J
Scand J Rheumatol; 2016 Oct; 45(5):429-31. PubMed ID: 27050436
[No Abstract] [Full Text] [Related]
10. Primary diffuse large B-cell lymphoma of the palpebral conjunctiva.
Kim NJ; Khwarg SI
Can J Ophthalmol; 2007 Aug; 42(4):630-1. PubMed ID: 17641717
[No Abstract] [Full Text] [Related]
11. Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
Hofman MS; Fields P; Yung L; Mikhaeel NG; Ireland R; Nunan T
Br J Haematol; 2007 Jun; 137(5):386. PubMed ID: 17355259
[No Abstract] [Full Text] [Related]
12. Eyelid primary diffuse large B-cell lymphoma.
Huerva V; Canto LM
Can J Ophthalmol; 2008 Apr; 43(2):240-1. PubMed ID: 18347633
[No Abstract] [Full Text] [Related]
13. Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment.
Blumenfeld Z; Benaroush M; Zuckerman T
Hum Reprod; 2007 Aug; 22(8):2346. PubMed ID: 17452395
[No Abstract] [Full Text] [Related]
14. [Standard therapy and research questions in diffuse large B-cell lymphoma].
Yamamoto K
Rinsho Ketsueki; 2012 Oct; 53(10):1634-48. PubMed ID: 23037736
[No Abstract] [Full Text] [Related]
15. Relapsed/refractory diffuse large B-cell lymphoma: on the threshold of new therapies.
Sud R; Friedberg JW
Oncology (Williston Park); 2009 Jun; 23(7):615-6, 619. PubMed ID: 19626828
[No Abstract] [Full Text] [Related]
16. Therapeutic options in relapsed or refractory diffuse large B-cell lymphoma. Part 1. current treatment approaches.
Hernandez-Ilizaliturri FJ; Czuczman MS
Oncology (Williston Park); 2009 May; 23(6):546-53. PubMed ID: 19544696
[TBL] [Abstract][Full Text] [Related]
17. Attenuated immunochemotherapy for diffuse large B-cell lymphoma.
Miura K; Kobayashi Y; Hojo A; Hatta Y; Takeuchi J
Lancet Oncol; 2011 Aug; 12(8):725; author reply 725-6. PubMed ID: 21807340
[No Abstract] [Full Text] [Related]
18. Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
Biswas T; Dhakal S; Chen R; Hyrien O; Bernstein S; Friedberg JW; Fisher RI; Liesveld J; Phillips G; Constine LS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):79-85. PubMed ID: 19647953
[TBL] [Abstract][Full Text] [Related]
19. Graft-Versus-Lymphoma Effect Can Be Rapid and Potent in Diffuse Large B-Cell Lymphoma.
Rashidi A; Cashen A
Exp Clin Transplant; 2016 Aug; 14(4):460-2. PubMed ID: 27506261
[No Abstract] [Full Text] [Related]
20. Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study.
van Imhoff GW; McMillan A; Matasar MJ; Radford J; Ardeshna KM; Kuliczkowski K; Kim W; Hong X; Goerloev JS; Davies A; Barrigón MDC; Ogura M; Leppä S; Fennessy M; Liao Q; van der Holt B; Lisby S; Hagenbeek A
J Clin Oncol; 2017 Feb; 35(5):544-551. PubMed ID: 28029326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
